InsightRx profile picture
InsightRx Erstellt neuen Artikel
3 d

Genomics in Cancer Care Market: Explosive Growth as Liquid Biopsy, Minimal Residual Disease Testing, and Non-Invasive Genomic Monitoring Redefine Cancer Management | #healthcare

Genomics in Cancer Care Market: Explosive Growth as Liquid Biopsy, Minimal Residual Disease Testing, and Non-Invasive Ge

The market was valued at roughly USD 46.6–53.7 billion in 2024–2025 and is projected to reach about USD 219–220 billion by 2035

© 2026 Yajoop

Sprache